Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3219 |
7,8-Didehydrocimigenol
|
ERK; IκB/IKK; TNF; NF-κB; Akt; PPAR | Apoptosis; Cytoskeletal Signaling; DNA Damage/DNA Repair; MAPK; Metabolism; NF-κB; PI3K/Akt/mTOR signaling |
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression. |